Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, March 2007, p. 1115-1118, Vol. 51, No. 3
0066-4804/07/$08.00+0 doi:10.1128/AAC.00725-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Gut Health Division, Rowett Research Institute, Bucksburn, Aberdeen, United Kingdom AB21 9SB
Received 12 June 2006/ Returned for modification 21 August 2006/ Accepted 1 November 2006
|
|
|---|
|
|
|---|
80% amino acid sequence identity fall into 40 different gene classes (1, 4, 9), conferring resistance by 4 different mechanisms (2). Various mosaic ribosomal protection genes, presumably arising by recombination between wild-type genes, have been discovered recently. Mosaic tet(O/W) genes were prevalent in Megasphaera elsdenii isolates from swine farms in the United States (11) and conferred a higher level of resistance than the original tet(O) or tet(W) gene (12). The tet(32) ribosomal protection gene also exhibits a high level of resistance to tetracycline (6). This gene was recently reclassified as tet(O/32/O) (13), since the novel tet(32) sequence, which shares only 60% identity with tet(O) sequences, is limited to the central portion of the gene product. The nomenclature for these hybrid tet genes reflects the regions of similarity to known genes (5). In this study we investigated whether such hybrid tet genes represent occasional variants or whether they account for a significant proportion of ribosomal protection tet genes. Incidence of mosaic tetracycline resistance genes in a range of environmental samples. Mixed animal fecal samples (8), mainly from pig herds reared either intensively or organically (Table 1), and mixed human fecal and saliva samples from several countries were used for DNA extraction with the FastDNA SPINKit for soil (Qbiogene, Irvine, CA). Sample Ab1 was a single sample from an individual with a history of long-term tetracycline therapy (10), from whom the bacterium carrying the tet(O/32/O) gene had previously been isolated (6, 13).
|
View this table: [in a new window] |
TABLE 1. PCR results obtained with human fecal and saliva samples and animal fecal DNA samples from across Europea
|
![]() View larger version (7K): [in a new window] |
FIG. 1. Schematic showing primer combinations, annealing temperatures, and expected product sizes for PCR amplification of tet(O), tet(W), and various mosaic Tcr genes. 1), full-length tet(O) product, tetOFF2 (5'-TTGTTTTGGGGCTATTGGAG-3') plus tetOFR3 (5'-TATATGACTTTTGCAAGCTG-3'); 2), full-length tet(W) product, tetWFF (5'-TTGGGGCTGTAAAGGGAGGAC-3') plus tetWFR (5'-CTTTACATTACCTTCTGA-3'); 3), tet(O/W) product, tetOFF2 plus tetWarray_rev (5'-AATCTTACAGTCCGTTACG-3'); 4), tet(O/32) product, tetOFF2 plus tet32(2)array_rev (5' CTCTTTCATAGCCACGCC 3'); 5), tet(W/32) internal product, tetWarray for (5'-GGAGGAAAATACCGACATA-3') plus tet32(2)array_rev; 6), tet(W/32) 5' end, tetWFF plus tet32(2)array_rev; 7), tet(W/32) product from nested PCR using tet(O) full-length product as a template, tetW412for (5'-AGAGCGTGGTTCAGTCTGTT-3') plus tet32(2)-array_rev; 8), tet32(2)array_for (5'-AACCGAAGCATACCGCTC-3') plus tet32(2)array_rev.
|
The majority of clones from the Spanish pigs carried mosaic genes (Fig. 2), and only 22% (14/64) contained the nonmosaic tet(O) gene. Crossover positions for each sequence were compared in order to identify hot spots for recombination. All 32 tet(O/W/32/O) amplicons had identical crossover points (Fig. 2C), and 9 tet(O/W/O) sequences were identical, with 1 changing back to tet(O) at position 1263 (Fig. 2B). None of these resembled tet(O/W/O) genes described previously (11). Three tet(O/32/O) genes were identical (Fig. 2E), while the other four were all different, with one the same as the previously described tet(O/32/O) gene (Fig. 2F) (13). One complex clone had an insert that aligned to tet(O/W/32/O/W/O) (Fig. 2G).
![]() View larger version (11K): [in a new window] |
FIG. 2. Schematic representation of mosaic tetracycline resistance genes from the fecal material of Spanish pig herd 1. Stippled regions indicate gene segments sharing high sequence identity with C. jejuni tet(O) (accession no. M18896). Open regions represent high sequence identity with B. fibrisolvens tet(W) (accession no. AJ222769). Hatched areas have a high level of similarity to the tet(32) region of the tet(O/32/O)-1 gene from Clostridium sp. strain K10 (accession no. AJ295238). Mosaic genes produced by recombination between the same tet classes at different crossover positions are differentiated by italicized numbers. *, tet(O/W/O)-1 and -2 were identified previously (11). **, three other tet(O/32/O) mosaics were also identified, tet(O/32/O)-3, -4, and -5, changing at positions 882 and 1263, 876 and 1248, and 867 and 1307, respectively.
|
Sequencing of Italian pig 1 clones amplified using the primer combination PCR 6 (Fig. 1) showed that other tetracycline resistance mosaic genes, including some derived from tet(W), remain to be discovered.
It has been suggested that a minimum stretch of 50 amino acids may be appropriate in defining a mosaic protein (5). However, the central tet(O) sequence in the tet(O/W/32/O/W/O) mosaic encodes 16 amino acids (Fig. 2G) and thus does not fit this description. The problems of nomenclature clearly increase with the complexity of the mosaic gene.
Tetracycline resistance mosaic genes can confer greater resistance than the wild-type genes (12). We attempted to determine the tetracycline resistance conferred by T-vector clones containing amplicons (Fig. 1, PCR 1) of each type of mosaic gene shown in Fig. 2 compared to that with the wild-type genes in an E. coli host. Only one of the clones gave any significant resistance: the tet(O/W/32/O/W/O) mosaic grew in 64 µg ml1 tetracycline (results not shown). Upstream sequences of
300 nucleotides, absent here, have been shown to be essential for full expression of resistance for tet(O) (14) and tet(W) (7). The multiple mosaic may indeed confer a high level of resistance, but protein expression levels have not been determined.
Identification of tet(32). During this work, a human oral bacterium (identified by full 16S rRNA sequencing as Streptococcus salivarius strain FStet12) was isolated that contained an internal tet(32) sequence (Fig. 1, PCR 8), but no product was amplified using the tet(O)-tet(32) primers (PCR 4). Genome walking (3) was used to complete the gene sequence, which was presumed to be the original, nonmosaic form of tet(32). The central region of the Tet(32) protein (amino acids 74 to 424) is >99% identical to the Tet(O/32/O) mosaic protein but otherwise the full-length protein has only 66% identity to its closest relatives, Tet(O) and Tet(W). The presence of tet(32) in S. salivarius FStet12 was confirmed by sequencing the full-length gene amplified from purified bacterial DNA. It is interesting that the tet(32) gene was identified in an environment that lacks mosaic genes (Table 1).
Conclusions. In conclusion, this European study of humans and animals demonstrates that tetracycline resistance genes of the mosaic ribosome protection type, at least based on tet(O), are widespread and are as abundant as nonmosaics in some samples. These genes may influence the results of surveillance programs investigating the incidence of specific tetracycline resistance genes. In the case of tet(32), the abundance of mosaic combinations delayed identification of the full-length gene.
Nucleotide sequence accession numbers. The sequence of tet(32) has been deposited in the GenBank database under accession number DQ647324. The sequence of a representative of each type of mosaic gene has been deposited in the GenBank database under accession numbers DQ679926 [tet(O/W/32/O/W/O)], EF065523 [tet(O/W/32/O)], and EF065524 [tet(O/W/O)-3].
This study was carried out with financial support from the Commission of the European Communities, specific RTD program, "Quality of Life and Management of Living Resources": QLK2-CT-2002-00843, "Antimicrobial resistance transfer from and between gram-positive bacteria of the digestive tract and consequences for virulence (ARTRADI)," and QLRT-2001-02056, "Gene mining of Metagenomes for novel enzymes and therapeutics (GEMINI)." RRI receives support from the Scottish Executive Environment and Rural Affairs Department (SEERAD).
Published ahead of print on 18 December 2006. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»